US deal raises medicines spending and the NICE threshold in return for US tariff relief. Critics focus on opportunity-cost, ...
How is Trump’s Most Favoured Nation pricing reshaping global medicine access? OHE’s World Health Summit panel examines MFN’s ...
The OHE Annual Lecture is our opportunity to highlight urgent and important issues facing health systems around the world. OHE’s educational mission is to support, sustain, and enhance the discipline ...
The OHE Annual Lecture is our opportunity to highlight urgent and important issues facing health systems around the world. OHE’s educational mission is to support, sustain, and enhance the discipline ...
The OHE Annual Lecture is our opportunity to highlight urgent and important issues facing health systems around the world. OHE’s educational mission is to support, sustain, and enhance the discipline ...
A new OHE study, funded and commissioned by argenx, finds rising demand, import dependence and increasing costs may strain the UK’s future supply of immunoglobulin.
In this episode of A Dose of Economics, Grace Hampson sits down with OHE’s Amanda Cole and global market access consultant Neil Grubert to discuss the biggest developments in U.S drug pricing policy – ...
A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational mission is to support, sustain, and enhance the discipline of health ...
A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational mission is to support, sustain, and enhance the discipline of health ...
The OHE Annual Lecture is our opportunity to highlight urgent and important issues facing health systems around the world. OHE’s educational mission is to support, sustain, and enhance the discipline ...
A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational mission is to support, sustain, and enhance the discipline of health ...
ASCVD drives major global health and economic burden, with LDL-C responsible for up to one-third. Better prevention and management could reduce costs and save lives.